Related Experiment Video
Updated: Dec 17, 2025

Isolation of Human Primary Valve Cells for In vitro Disease Modeling
Published on: April 16, 2021
Aortic valve: anatomy and structure and the role of vasculature in the degenerative process
Vasiliki Katsi1, Nikolaos Magkas1, Alexios Antonopoulos1
1First Department of Cardiology, 'Hippokration' Hospital, Medical School, University of Athens, Athens, Greece.
Insights
Aortic valve stenosis involves active processes like inflammation and new vessel formation (neoangiogenesis). While animal studies suggest neoangiogenesis worsens this condition, more human data is needed to confirm its role and therapeutic potential.
Area of Science:
- Cardiovascular Biology
- Pathophysiology
- Vascular Biology
Background:
- Aortic valve stenosis (AVS) is a degenerative disease characterized by valve thickening, calcification, and fibrosis.
- AVS is an active process involving inflammation, oxidative stress, calcification, and neoangiogenesis, not just passive calcium deposition.
- The normal aortic valve is avascular, but stenotic valves exhibit micro-vasculature linked to disease progression.
Purpose of the Study:
- To review the role of neoangiogenesis in the pathogenesis of aortic valve stenosis.
- To discuss the current understanding of valve vasculature in calcification and stenosis.
- To highlight the need for further human studies on neoangiogenesis in AVS.
Main Methods:
- Literature review focusing on the pathophysiology of aortic valve stenosis.
- Analysis of existing data on valve vasculature and its association with AVS.
- Examination of animal and human studies regarding neoangiogenesis in AVS.
Main Results:
- Neoangiogenesis (new vessel formation) is present in stenotic aortic valves and associated with inflammation and calcification.
- Animal studies suggest neoangiogenesis may actively contribute to AVS progression.
- Robust evidence from human studies is lacking to fully elucidate the role of neoangiogenesis in AVS.
Conclusions:
- Neoangiogenesis is a key feature in the development of aortic valve stenosis.
- The precise role of neoangiogenesis in AVS (compensatory vs. detrimental) requires further investigation, particularly in human subjects.
- Understanding neoangiogenesis may offer future therapeutic targets for AVS, a condition lacking effective medical treatments.
Abstract:
Aortic valve stenosis is a degenerative disease affecting increasing number of individuals and characterised by thickening, calcification and fibrosis of the valve resulting in restricted valve motion. Degeneration of the aortic valve is no longer considered a passive deposition of calcium, but an active process that involves certain mechanisms, that is endothelial dysfunction, inflammation, increased oxidative stress, calcification, bone formation, lipid deposition, extracellular matrix (ECM) remodelling and neoangiogenesis. Accumulating evidence indicates an important role for neoangiogenesis (i.e. formation of new vessels) in the pathogenesis of aortic valve stenosis. The normal aortic valve is generally an avascular tissue supplied with oxygen and nutrients via diffusion from the circulating blood. In contrast, presence of intrinsic micro-vasculature has been demonstrated in stenotic and calcified valves. Importantly, presence and density of neovessels have been associated with inflammation, calcification and bone formation. It remains unclear whether neoangiogenesis is a compensatory mechanism aiming to counteract hypoxia and increased metabolic demands of the thickened tissue or represents an active contributor to disease progression. Data extracted mainly from animal studies are supportive of a direct detrimental effect of neoangiogenesis, however, robust evidence from human studies is lacking. Thus, there is inadequate knowledge to assess whether neoangiogenesis could serve as a future therapeutic target for a disease that no effective medical therapy exists. In this review, we present basic aspects of anatomy and structure of the normal and stenotic aortic valve and we focus on the role of valve vasculature in the natural course of valve calcification and stenosis.
More Related Videos
05:47Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Aortic Regurgitation I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Structure of Blood Vessels